T
a
THIS STUDY WAS SUPPORTED BY A GRANT PHRC-K 18–070 FROM THE FRENCH GOVERNMENT. IBRUTINIB WAS PROVIDED BY JANSSEN AND LENALIDOMIDE WAS PROVIDED BY BMS. THE PHARMACEUTICAL PARTNERS DID NOT PROVIDE WITH OTHER FUNDINGS , And Did Not Participate In The Conception
Last name: THIS STUDY WAS SUPPORTED BY A GRANT PHRC-K 18–070 FROM THE FRENCH GOVERNMENT. IBRUTINIB WAS PROVIDED BY JANSSEN AND LENALIDOMIDE WAS PROVIDED BY BMS. THE PHARMACEUTICAL PARTNERS DID NOT PROVIDE WITH OTHER FUNDINGS
First name: And Did Not Participate In The Conception
No publications collected so far.